Drug Type CAR-T |
Synonyms AntiCD123 CARTcell therapy Wuhan Bio Raid Biotechnology |
Target |
Mechanism CD123 inhibitors(Interleukin-3 receptor subunit alpha inhibitors), Gene transference, T lymphocyte replacements |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Myeloid Leukemia | Phase 1 | CN | 20 Jun 2019 |